Brawn Biotech Limited (BOM:530207)

India · Delayed Price · Currency is INR

21.05

-1.05 (-4.75%)

At close: Nov 6, 2026

Brawn Biotech Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	180.9	169.78	134.65	164.95	222.36	86.21
Revenue Growth	7.66%	26.09%	-18.37%	-25.82%	157.93%	-75.35%
Gross Profit	26.36	23.72	13.73	19.73	29.11	17.33
Operating Income	-1.96	-0.73	-18.76	-15.63	-4.05	-20.57
Net Income	8.18	9.41	-17.4	-12.47	-8.68	-16.44
Earnings Per Share	2.64	3.14	-5.80	-4.16	-2.89	-5.48
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	145.32	119.74	155.28	206.74	79.54
Unallocated	24.46	14.91	9.67	15.57	6.67
Total	169.78	134.65	164.95	222.31	86.21

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	1.87	2.81	1.99	3.97	4.39	2.25
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	1.87	2.81	1.99	3.97	4.39	2.25
Net Cash Growth	-1.11%	40.70%	-49.80%	-9.46%	95.36%	-43.31%
Net Cash Per Share	0.61	0.94	0.66	1.32	1.46	0.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	0.72	1.12	0.47	-0.26	3.18	1.88
Capital Expenditures	-0.02	-0.26	-2.42	-0.12	-0.96	-2.97
Free Cash Flow	0.71	0.86	-1.94	-0.38	2.22	-1.09
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	14.57%	13.97%	10.20%	11.96%	13.09%	20.10%
Operating Margin	-1.09%	-0.43%	-13.93%	-9.48%	-1.82%	-23.86%
Pretax Margin	-0.67%	0.01%	-13.35%	-9.36%	-1.85%	-24.57%
Profit Margin	4.52%	5.54%	-12.92%	-7.56%	-3.90%	-19.07%
FCF Margin	0.39%	0.50%	-1.44%	-0.23%	1.00%	-1.27%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	7.96	6.65	-	-	-	-
P/FCF Ratio	89.30	73.06	-	-	22.33	-
PS Ratio	0.35	0.37	0.36	0.36	0.22	0.60